Suppr超能文献

英格兰的宫颈癌筛查:过去、现在和未来。

Cervical screening in England: the past, present, and future.

机构信息

School of Cancer and Enabling Sciences, The University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.

出版信息

Cancer Cytopathol. 2012 Apr 25;120(2):87-96. doi: 10.1002/cncy.20203. Epub 2012 Feb 24.

Abstract

Cervical screening in England commenced in a disorganized fashion in 1964. The flaws of this approach became apparent in the mid-1980s and led to the inception of the National Health Service Cervical Screening Programme (NHSCSP). The main features of this program are its population-based registry, accessibility to all women within the screening age range, its systematic process of call and recall, national coordination, and quality assurance. Its success is in part based on its ability to evolve as evidence necessitates, and throughout the period of 2000-2010, it embarked upon a series of developments involving liquid-based cytology, which also provided the means to conduct reflex high-risk human papillomavirus (HR-HPV) testing and the potential to automate the screening process. As a result of evidence acquired since 2000, the NHSCSP is currently based on a system of primary cytology with HPV triage for low-grade abnormalities combined with cytology plus a HR-HPV "test of cure" for women who have received treatment for cervical intraepithelial neoplasia. Future challenges for the program will involve finding solutions to increasing screening uptake among women <30 years of age-a problem that may be exacerbated when vaccinated women reach the screening age, while making plans to accommodate HPV primary screening.

摘要

英格兰的宫颈癌筛查始于 1964 年,方式较为混乱。这种方法的缺陷在 20 世纪 80 年代中期变得明显,导致国家卫生服务宫颈癌筛查计划(NHSCSP)的诞生。该计划的主要特点是基于人群的登记系统,适用于所有处于筛查年龄段的女性,有系统的呼叫和召回程序,全国协调,以及质量保证。其成功部分基于其能够根据证据的需要不断发展的能力,在 2000 年至 2010 年期间,它进行了一系列涉及液基细胞学的发展,这也为进行高风险人乳头瘤病毒(HR-HPV)的反射性检测提供了手段,并有可能实现筛查过程的自动化。自 2000 年以来获得的证据表明,NHSCSP 目前基于一种细胞学初级筛查与 HPV 分流相结合的系统,用于低度异常,同时对接受宫颈癌前病变治疗的女性进行细胞学加 HR-HPV“治愈检测”。该计划未来的挑战将包括解决 30 岁以下女性筛查率上升的问题——当接种疫苗的女性达到筛查年龄时,这个问题可能会加剧,同时还需要计划容纳 HPV 初级筛查。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验